HT006.2.2
Asset
NGF eye drops promote corneal nerve survival and repair.
- Stage
- Phase 1
- Modality
- Protein or enzyme
- Target
- NTRK1
- 1
- Indication
- 0
- Trials
- 1
- Developer
Indications
1Neurotrophic keratitis
Phase 1, prnewswire.com, 13 Oct 2026
In the full profile
- Targets and what it contains1
- Owner and partners2
- Evidence for its targets1
- Signals2
Every asset’s record: target, stage, trials and the evidence behind it.